Injective Labs
The New Dawn of Decentralized Finance
New York, United States · Founded 2018 · $243.0M raised
- Headquarters
- New York, New York
- Employees
- 11–50
- Founded
- 2018
- Business Model
- B2B
- Website
- injectivelabs.org
- Total Funding
- $243.0M
- Last Round
- $40.0M Venture RoundMar 2026
- Rounds
- 5
About
Injective Labs is a research and development company building Web3 infrastructure and finance solutions, serving as a core contributor to the Injective blockchain. The company's products include Helix (a decentralized derivatives exchange), Mito (a DeFi yield protocol), and validator node operations across the Web3 ecosystem.
Summary
Injective Labs is a Crypto & Web3 company based in New York, United States, founded in 2018. It has raised $243.0M in total across 5 rounds, most recently a $40.0M Venture Round round in Mar 2026. Investors include Jump Crypto.
Tech & App Stack
18 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2026
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Regulated institutional-grade cryptocurrency exchange offering spot trading for Bitcoin, Ethereum...

Humanoid robotics company building general-purpose autonomous robots for commercial deployment

Enterprise-grade digital asset infrastructure platform enabling fintechs, banks, and payment prov...

FTX provides field service management and asset management solutions.

FTX Trading Ltd. was a cryptocurrency derivatives exchange and crypto hedge fund that filed for b...
Global Web3 financial infrastructure enabling fiat-to-crypto and crypto-to-fiat payment flows for...